Centeon Pharma GmbH
Records under this name other than patents Centeon Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,869,790 | Preparation of DNA encoding factor XIIIA Formerly held In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 7,220,556 | Preparation of factor XIIIa by gene manipulation Formerly held Term ended Term ended May 22, 2024 · From the USPTO record | Term ended | Term ended May 22, 2024 | From the USPTO record |
| US 6,746,866 | Preparation of factor XIIIa by gene manipulation Term ended Ended no later than Jun 8, 2021 · From the USPTO record | Term ended | Ended no later than Jun 8, 2021 | From the USPTO record |
| US 6,500,427 | One-component tissue adhesive and a process for the production thereof Formerly held Term ended Term ended Dec 31, 2019 · From the USPTO record | Term ended | Term ended Dec 31, 2019 | From the USPTO record |
| US 6,419,921 | DNA-constructs of blood clotting factors and P-Selectin Formerly held Term ended Term ended Nov 15, 2019 · From the USPTO record | Term ended | Term ended Nov 15, 2019 | From the USPTO record |
| US 6,310,267 | Flexible wound covering based on fibrin and process for its production Formerly held Term ended Term ended Nov 5, 2019 · From the USPTO record | Term ended | Term ended Nov 5, 2019 | From the USPTO record |
| US 6,207,877 | Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding Formerly held Term ended Term ended Sep 23, 2019 · From the USPTO record | Term ended | Term ended Sep 23, 2019 | From the USPTO record |
| US 6,399,356 | Process and agent for sanitation of contaminations caused by viruses Formerly held Term ended Term ended Jul 30, 2019 · From the USPTO record | Term ended | Term ended Jul 30, 2019 | From the USPTO record |
| US 6,528,299 | Protease for activating clotting factor VII Formerly held Term ended Term ended Apr 21, 2019 · From the USPTO record | Term ended | Term ended Apr 21, 2019 | From the USPTO record |
| US 6,346,277 | Process for the pasteurization of plasma or concentrates of blood coagulation factors II, VII, IX and X Formerly held Term ended Term ended Feb 12, 2019 · From the USPTO record | Term ended | Term ended Feb 12, 2019 | From the USPTO record |